Covalis Capital’s Celanese CE Stock Holding History

Covalis Capital’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,080	Closed	-$1.75M	–	41
2022 Q4	$1.75M	Buy	+17,080	New	+$1.69M	0.41%	39

Other funds holding CE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Covalis Capital's CE Position: Q1 2023 in Review

Covalis Capital sold out of Celanese (CE) in Q1 2023, closing a stake of 17,080 shares — an estimated $1.75M sold.

Covalis Capital first reported a position in CE in Q4 2022 and held it in 1 quarter. The position peaked at $1.75M in Q4 2022. 646 funds tracked by Wall St. Rank hold CE as of Q1 2023.

Covalis Capital reported no remaining Celanese position as of Q1 2023 after selling out during the quarter.
Covalis Capital sold 17,080 Celanese shares in Q1 2023, an estimated $1.75M.
Covalis Capital first reported a position in Celanese in Q4 2022 and held it in 1 quarter.
Covalis Capital's Celanese position peaked at $1.75M in Q4 2022.
646 funds tracked by Wall St. Rank held Celanese as of Q1 2023.

Based on Covalis Capital's 13F filing for Q1 2023, filed 15 May 2023.